AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Delaware

SB 262

Uniform Controlled Substances Act amendments

Status

Superseded by a new draft

2026

Original superseded by SS1 for SB262. Successor committee history does not establish current October pendency; no enactment verified.

IntroducedMar 18, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Type: Official legislature record
Substances: Kratom / 7-OH

Official text

Summary of official legislation

Original superseded by SS1 for SB262. Successor committee history does not establish current October pendency; no enactment verified.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: legis.delaware.gov

Legislative history

April 15, 2026
Replaced by SS1 for SB262.
March 18, 2026
Introduced.

Loading bill…